Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 152 citing Johnson: Decreased mortality associated with the use of metformin compared with sulfonylurea.... (0.07 sec) 

Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review

- juanncorpas.edu.co [PDF] 
DE DeWitt, IB Hirsch - Jama, 2003 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Newer insulin ...
Cited by 273 - Related articles - BL Direct - All 8 versions

Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart …


AE Caballero - Obesity, 2003 - nature.com
Obesity, insulin resistance, and endothelial dysfunction closely coexist
throughout the natural history of type 2 diabetes. They all can be identified
not only in people with type 2 diabetes, but also in various groups at risk ...
Cited by 181 - Related articles - BL Direct - All 7 versions

Improved clinical outcomes associated with metformin in patients with diabetes and heart …


DT Eurich, SR Majumdar, FA McAlister, RT … - Diabetes Care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—Using the Saskatchewan Health databases, 12,272
new users of oral antidiabetic agents were identified between the years 1991 and
1996. Subjects with incident heart failure (n = 1,833) were identified ...
Cited by 123 - Related articles - BL Direct - All 9 versions

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or …

- worldsign.in [PDF]  - Free from Publisher
SL Bowker, SR Majumdar, P Veugelers, JA … - Diabetes Care, 2006 - Am Diabetes Assoc
RESULTS—We identified 10,309 new users of metformin or sulfonylureas with an
average follow-up of 5.4 ± 1.9 years (means ± SD). The mean age for the cohort
was 63.4 ± 13.3 years, and 55% were men. Cancer mortality over follow-up ...
Cited by 102 - Related articles - BL Direct - All 8 versions

A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral …

- endojournals.org
E Diamanti-Kandarakis, JP Baillargeon, MJ … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc
The discovery of the central role of insulin resistance in PCOS is important
from several points of view, including the possibility that the traditional
management of the disorder may have untoward long-term consequences. The ...
Cited by 87 - Related articles - All 4 versions

The potential influence of inflammation and insulin resistance on the pathogenesis and …

- endojournals.org
P Dandona, A Aljada, A Chaudhuri, A … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc
The rationale for the treatment of diabetes has hitherto been directed to the
correction of hyperglycemia because hyperglycemia is known to be responsible for
the symptoms of polyuria and polydipsia in the short term and ...
Cited by 76 - Related articles - BL Direct - All 4 versions

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus …

- canadianmedicaljournal.ca
SH Simpson, SR Majumdar, RT Tsuyuki, DT … - Canadian Medical Association Journal, 2006 - canadianmedicaljournal.ca
Methods: This was a retrospective, inception cohort study using administrative
data from Saskatchewan Health (1991– 1999). The 5795 subjects, identified by
their first-ever dispensation for an oral antidiabetic agent, were grouped ...
Cited by 73 - Related articles - BL Direct - All 11 versions

Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes …

- canadianmedicaljournal.ca
LC Brown, JA Johnson, SR Majumdar, RT … - Canadian Medical Association Journal, 2004 - Can Med Assoc
Methods: Administrative records from Saskatchewan Health were used to evaluate
the use of antiplatelet agents, statins and angiotensin-converting enzyme (ACE)
inhibitors by people with treated type 2 diabetes with and without ...
Cited by 73 - Related articles - BL Direct - All 14 versions

Coronary heart disease outcomes in patients receiving antidiabetic agents


AT McAfee, C Koro, J Landon, N Ziyadeh, AM … - Pharmacoepidemiology and Drug Safety, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 74 - Related articles - BL Direct - All 5 versions

Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF …

- endojournals.org
P Dandona, A Aljada, H Ghanim, P Mohanty, C … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc
Forty obese subjects [body mass index (BMI), 37.5 ± 4.9 kg/m 2 ] and 40
nonobese healthy subjects (BMI, 22.6 ± 3.4 kg/m 2 ) had their plasma MIF,
glucose, insulin, free fatty acids (FFAs) and C-reactive protein (CRP) ...
Cited by 59 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google